ArticleNature communications2017

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches.

Virginie Mariot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.